Tarsus Pharmaceuticals
TARS
TARS
193 hedge funds and large institutions have $2.23B invested in Tarsus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 65 increasing their positions, 55 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
8.76% less ownership
Funds ownership: 114.07% → 105.3% (-8.8%)
74% less call options, than puts
Call options by funds: $4.57M | Put options by funds: $17.5M
Holders
193
Holding in Top 10
9
Calls
$4.57M
Puts
$17.5M
Top Buyers
| 1 | +$106M | |
| 2 | +$37.9M | |
| 3 | +$23.3M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$22M |
| 5 |
Jennison Associates
New York
|
+$17.8M |
Top Sellers
| 1 | -$61.4M | |
| 2 | -$29M | |
| 3 | -$23.7M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$23.4M |
| 5 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$22.9M |